The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124892582 12489258 2 F 20160728 20160622 20160802 EXP US-ALLERGAN-1660298US ALLERGAN GILL K, BAYART C, DESAI R, GOLDEN A, RAIMER P, AND TAMBURRO J. BRIMONIDINE TOXICITY SECONDARY TO TOPICAL USE FOR AN ULCERATED HEMANGIOMA. PEDIATRIC DERMATOLOGY. 2016;33(4):1-3 8.00 WK F Y 3.15000 KG 20160802 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124892582 12489258 1 PS BRIMONIDINE BRIMONIDINE TARTRATE 1 Topical 2 GTT, FOUR HOURS LATER APPLIED IN THE SAME AMOUNT Y U 20613 2 GTT EYE DROPS, SOLUTION
124892582 12489258 2 SS TIMOLOL MALEATE. TIMOLOL MALEATE 1 Topical 2 GTT, FOUR HOURS LATER APPLIED IN THE SAME AMOUNT Y U 0 2 GTT EYE DROPS, SOLUTION
124892582 12489258 3 C PROPRANOLOL HCL 10mg Tab 2 Oral 4 MG/KG, QD 0 4 MG/KG TABLET QD
124892582 12489258 4 C PROPRANOLOL HCL 10mg Tab 2 3 MG/KG, QD 0 3 MG/KG TABLET QD
124892582 12489258 5 C PROPRANOLOL HCL 10mg Tab 2 1 MG/KG, QD 0 1 MG/KG TABLET QD
124892582 12489258 6 C PREDNISOLONE ACETATE, 1.0% PREDNISOLONE ACETATE 1 Oral 2 MG/KG, QD 0 2 MG/KG EYE DROPS, SUSPENSION QD
124892582 12489258 7 C PREDNISOLONE ACETATE, 1.0% PREDNISOLONE ACETATE 1 Oral 1 MG/KG, QD 0 1 MG/KG EYE DROPS, SUSPENSION QD
124892582 12489258 8 C LIDOCAINE. LIDOCAINE 1 Topical UNK, UNK 0
124892582 12489258 9 C OXYCODONE OXYCODONE 1 Oral .05 MG/KG, UNK Y U 0 .05 MG/KG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124892582 12489258 1 Ulcerated haemangioma
124892582 12489258 2 Ulcerated haemangioma
124892582 12489258 3 Ulcerated haemangioma
124892582 12489258 6 Ulcerated haemangioma
124892582 12489258 8 Ulcerated haemangioma
124892582 12489258 9 Ulcerated haemangioma

Outcome of event

Event ID CASEID OUTC COD
124892582 12489258 HO
124892582 12489258 OT
124892582 12489258 LT

Reactions reported

Event ID CASEID DRUG REC ACT PT
124892582 12489258 Depressed level of consciousness
124892582 12489258 Hypothermia
124892582 12489258 Hypotonia
124892582 12489258 Infantile apnoea
124892582 12489258 Lethargy
124892582 12489258 Off label use
124892582 12489258 Respiratory depression
124892582 12489258 Toxicity to various agents

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found